Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Arcadia Biosciences, Inc. (RKDA : NSDQ)

• Company Description    Arcadia Biosciences Inc. is a producer and marketer of plant-based health and wellness products. Arcadia Biosciences Inc. is based in DALLAS. Number of Employees: 9

• Price / Volume Information    Yesterday's Closing Price: $3.69 Daily Weekly Monthly 20 Day Moving Average: 1,343,698 shares Shares Outstanding: 1.37 (millions) Market Capitalization: $5.04 (millions) Beta: 0.57 52 Week High: $7.08 52 Week Low: $2.53 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 4.24% 1.51% 12 Week -20.65% -23.93% Year To Date -37.67% -45.52%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5950 Sherry Lane SUITE 215 - Dallas,TX 75225 USA ph: 214-974-8921 fax: 530-756-7027 ir@arcadiabio.com http://www.arcadiabio.com

• General Corporate Information    Officers Thomas J. Schaefer - President and Chief Executive Officer Mark Kawakami - Chief Financial Officer Albert D. Bolles - Director Kevin Comcowich - Director Lilian Shackelford Murray - Director Peer Information Arcadia Biosciences, Inc. (CORR.) Arcadia Biosciences, Inc. (RSPI) Arcadia Biosciences, Inc. (CGXP) Arcadia Biosciences, Inc. (BGEN) Arcadia Biosciences, Inc. (GTBP) Arcadia Biosciences, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 039014303 SIC: 1311 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/19/26 Share - Related Items Shares Outstanding: 1.37 Most Recent Split Date: 3.00 (0.03:1) Beta: 0.57 Market Capitalization: $5.04 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/19/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.11 Price/Cash Flow: - Price / Sales: 0.98 EPS Growth vs. Year Ago Period: 171.26% vs. Previous Quarter: 3,000.00% Sales Growth vs. Year Ago Period: -15.29% vs. Previous Quarter: -10.52% ROE 09/30/25 - -8.42 06/30/25 - -34.75 03/31/25 - -16.94 ROA 09/30/25 - -4.83 06/30/25 - -20.91 03/31/25 - -10.56 Current Ratio 09/30/25 - - 06/30/25 - 4.12 03/31/25 - 3.99 Quick Ratio 09/30/25 - - 06/30/25 - 3.31 03/31/25 - 3.41 Operating Margin 09/30/25 - -10.67 06/30/25 - -47.90 03/31/25 - -29.67 Net Margin 09/30/25 - -97.97 06/30/25 - -139.36 03/31/25 - -38.34 Pre-Tax Margin 09/30/25 - - 06/30/25 - -130.77 03/31/25 - -14.51 Book Value 09/30/25 - - 06/30/25 - 3.32 03/31/25 - 6.51 Inventory Turnover 09/30/25 - - 06/30/25 - 2.98 03/31/25 - 3.17 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©